carbachol has been researched along with Cleft Spine in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| German, K | 1 |
| Bedwani, J | 1 |
| Davies, J | 1 |
| Brading, AF | 1 |
| Stephenson, TP | 1 |
| Nergårdh, A | 1 |
| von Hedenberg, C | 1 |
| Hellström, B | 1 |
| Ericsson, NO | 1 |
2 other studies available for carbachol and Cleft Spine
| Article | Year |
|---|---|
Physiological and morphometric studies into the pathophysiology of detrusor hyperreflexia in neuropathic patients.
Topics: Adult; Carbachol; Dose-Response Relationship, Drug; Electric Stimulation; Female; Humans; In Vitro T | 1995 |
Continence training of children with neurogenic bladder dysfunction.
Topics: Adolescent; Adult; Age Factors; Carbachol; Child; Child, Preschool; Constipation; Diazepam; Ephedrin | 1974 |